The U.S. Food and Drug Administration has recalled certain infant formulas, according to a DPH news update issued May 4, 2026. The recall applies specifically to A2 Platinum USA label infant formula intended for infants zero to 12 months of age. As of the announcement, no further details about the reason for the recall, specific lot numbers, or manufacturing dates have been released.

Infant formula recalls command urgent attention because formula is the sole source of nutrition for many babies. Contamination, mislabeling, or nutrient deficiencies can cause serious health risks, including gastrointestinal illness, malnutrition, or heavy-metal exposure. The FDA typically initiates a recall when a product violates federal safety standards, whether due to a manufacturing defect, a packaging error, or a confirmed contaminant. Without an official cause, parents and caregivers are left with incomplete information, which makes it essential to follow standard recall protocols.

What is known about the recall

The DPH news update — likely issued by a state or local Department of Public Health — flags the product as A2 Platinum USA label infant formula for ages zero to 12 months. The label distinguishes it from other A2 Platinum formulas sold outside the United States or under different branding. The name suggests it contains A2 beta-casein protein, a variant marketed as easier to digest than conventional A1 protein. But the recall is not related to any specific ingredient claims; it is a regulatory action.

Parents who use A2 Platinum USA formula should check their supply immediately. Look for the brand name "A2 Platinum USA" on the front of the container, along with an age range of 0–12 months. If you have a container, do not feed it to your baby until you can verify whether it falls under the recall. The FDA and the manufacturer will eventually identify affected lot numbers, but that information has not yet been published. In the meantime, assume that any container of this specific label and age range may be included unless the manufacturer clarifies otherwise.

What parents should do now

1. Stop using the formula immediately. Until lot numbers are known, the safest course is to stop feeding any A2 Platinum USA formula for infants 0–12 months. If you have an unopened container, set it aside. If you have an opened container, discard the remaining powder.

2. Check for official updates. Bookmark the FDA’s recall page and the manufacturer’s website. The recall notice will be updated with lot codes, expiration dates, and UPC numbers once they are available. You can also sign up for FDA email alerts.

3. Contact your pediatrician. If your baby has consumed this formula and shows symptoms such as vomiting, diarrhea, unusual fussiness, or poor feeding, call your doctor. The FDA will eventually advise on whether medical testing is warranted, but your pediatrician can offer immediate guidance.

4. Find a replacement formula. Consult your pediatrician for a suitable alternative. Do not dilute formula to stretch the supply, and do not switch to cow’s milk for infants under 12 months unless a doctor recommends it. Many major brands — Similac, Enfamil, Gerber Good Start — produce comparable A2-based or standard formulas. Your doctor can help choose one that matches your baby’s needs.

5. Save the packaging. If you have a container, keep the label or take a photo. Lot numbers and expiration dates will be needed for a refund or for future identification. The manufacturer is required to provide remediation details once the recall scope is finalized.

Unanswered questions

At the time of the announcement, the FDA has not disclosed:

• Whether the recall is due to bacterial contamination (such as Cronobacter sakazakii or Salmonella), a nutrient imbalance, a packaging defect, or an undeclared allergen.
• Which specific lot numbers, production dates, or distribution regions are affected.
• How the product is being handled — whether consumers can return it to the store, get a refund, or receive a replacement.
• Whether any illnesses or adverse events have been linked to the formula.

This lack of detail is unusual for an FDA recall, which typically includes a press release with these specifics. The minimal information could mean the investigation is still early — a voluntary recall was initiated based on a potential problem that has not yet been fully characterized. Alternatively, it could reflect a state-level notice that precedes a federal announcement. Either way, the timeline matters: formula recalls during 2026 evoke comparisons to the 2022 nationwide shortage triggered by a massive recall and plant closure. Any recall, even a small one, can disrupt supply chains and spur panic buying, so clear communication from regulators is critical.

Broader context of infant formula safety

The FDA regulates infant formula as a special category of food under the Federal Food, Drug, and Cosmetic Act. Manufacturers must register with the agency, follow current good manufacturing practices, and submit premarket notifications for new formulas. Recalls are classified into three tiers: Class I (reasonable probability of serious health consequences), Class II (temporary or medically reversible effects), and Class III (violations unlikely to cause adverse health). Without the classification for this recall, it is impossible to assess the risk level.

Parents should be aware that formula recalls, though alarming, are part of a functioning safety system. The 2022 formula crisis — triggered by a Cronobacter outbreak at an Abbott Nutrition facility — led to tightened FDA oversight, increased inspections, and a new push for supply chain diversity. Since then, the agency has also finalized updates to its recall communication protocols, including faster public alerts and more detailed outbreak investigations. The brevity of this recall notice may simply reflect an early stage, not a failure of the system.

What to expect next

Within days, the FDA and the manufacturer will issue a formal press release with the specific product identifiers. Stay tuned to official channels, not social media rumors. The manufacturer’s customer service line will eventually be available for questions and refunds. If you have already purchased the formula, keep your receipt. If you are a retailer, check your inventory and remove the product from shelves.

The bottom line: Do not panic, but do act. Stop using A2 Platinum USA 0–12 month formula until you know your specific container is safe. Monitor FDA.gov and your pediatrician’s office for updates. This recall may be small in scope, but for the families using this product, it is a serious disruption. Accurate information will follow; until then, caution is the only reasonable response.

SysCall News will update this article as more information becomes available.